Saturday, March 25, 2006


Hepatitis C Therapy - Harvard Medical School - Online CME


Harvard Medical School - Online CME
Chronic hepatitis C afflicts 170 million individuals worldwide and is a major cause of morbidity and mortality. We discuss the various modes of acquisition of hepatitis C.

Chronic Hepatitis C
Chronic Hepatitis C The hepatitis C virus (HCV) is one of the most important causes of chronic liver disease in the United States.

SFCC :: STD Basics : Hepatitis
Chronic Hepatitis C (HCV) is the leading cause for liver transplants. How many people have it? It is estimated that there are between 125,000 and 200,000 Hepatitis A infections (HAV) per year in the

Chronic Hepatitis C: Sustained
Chronic Hepatitis C: Sustained Treatment Response (SVR) Interferon alfa-2a monotherapy ~ 15% Peg-Interferon alfa-2a monotherapy ~ 30% Interferon alfa-2b with ribavirin ~ 45%

Hepatitis C Therapy - Hepatitis C -- Sharara et al. 125 (8): 658 -- Annals of Internal Medicine


Hepatitis C -- Sharara et al. 125 (8): 658 -- Annals of Internal Medicine
... McAllister HA Jr, et al. The declining risk of post-transfusion hepatitis C infection. N Engl J Med ... Z, Samdal HH, Haaland T. Hepatitis C infection in patients with primary ...

Who Is at Risk for Hepatitis C?
Know your risk factors for hepatitis C! Even people in high-risk groups can take precautions to prevent HCV infection.

Screening: Hepatitis C Virus Infection
U.S. Preventive Services Task Force. Screening for Hepatitis C in Adults. Release Date: March 2004. Summary of Recommendation

Hawaii AETC | Links
... Diabetes Mellitus After Cessation of Interferon-Alpha Therapy for Chronic Hepatitis C Infection (PDF ... Gender Differences in Hepatitis C Infection and Risks Among Persons with Severe ...

Hepatitis C Therapy - The Best Option for Hepatitis C Therapy


The Best Option for Hepatitis C Therapy
The Option Care Advantage...A Patient Focused Specialty Pharmacy Option Care has been a healthcare pioneer since 1979. Option Care is unique, as we provide ...

Hepatitis Information Network: HepNet - Hepatitis C
Can the cost-effectiveness of hepatitis C therapy to other well accepted medical interventions be compared? Dr. Jong Wong, from the New England Medical ...

Hepatitis C
Teaching Materials; Patient Education; Hepatitis C / therapy; Hepatitis C / prevention & control; ... Hepatitis C / therapy ...

Side Effects Guide: Hepatitis C Therapy
Some medications may affect you in unwanted ways. This document was written for veterans, patients and people interested in learning the basics about ...

Thursday, March 23, 2006


Hepatitis C Therapy - MIGENIX Third Quarter Fiscal 2006 Financial Results Conference Call & Web Cast Notification


MIGENIX Third Quarter Fiscal 2006 Financial Results Conference Call & Web Cast Notification
[Press Release] PR Newswire via Yahoo! Finance - Mar 02 12:58 PM
MIGENIX Inc. , a clinical-stage developer of drugs for infectious and degenerative diseases, will host a conference call and web cast on Wednesday, March 8th, 2006 at 11:00 a.m. ET to discuss financial results for the third quarter of fiscal year 2006 ended January 31, 2006 and provide an update on company activities.Save to My Web

Human Genome Sciences Reports Positive Interim Results of Phase 2 Trial of Albuferon(TM) In Combination With Ribavirin
[Press Release] PR Newswire via Yahoo! Finance - Mar 14 5:01 AM
Human Genome Sciences, Inc. today reported the interim results of a Phase 2 clinical trial to evaluate the safety, tolerability and efficacy of Albuferon in combination with ribavirin in patients with chronic hepatitis C who failed to respond to previous interferon alpha-based treatment regimens.Save to My Web

euro adhoc: Intercell AG / Financial Figures/Balance Sheet / Intercell announces preliminary 2005 full year
vwd.de - Mar 05 10:43 PM
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement.Save to My Web

euro adhoc: Intercell AG / Financial Figures/Balance Sheet / Intercell announces preliminary 2005 full year results:
Presseportal - Mar 05 10:29 PM
06.03.2006 Intercell announces preliminary 2005 full year results: Good progress in product development - significant increase in revenues - strong cash ...Save to My Web

ViRexx Presents Hepatitis C Chimigen'TM' Technology at Baculovirus & Insect Cell Culture Annual Meeting
[Press Release] Business Wire via Yahoo! Finance - Feb 22 5:00 AM
EDMONTON, Alberta----Feb. 22, 2006--ViRexx Medical Corp. , a company focused on immunotherapy treatments for certain cancers, chronic hepatitis B & C and embolotherapy treatments for tumors, today announced that Rajan George, Ph.D., Vice President Research and Development of ViRexx, made a presentation about the Company's Chimigen technology for hepatitis C at the 9th Annual Meeting of the Save to My Web

Hepatitis C Therapy - If You Have Hepatitis C Infection - Liver Health Information - The ...


If You Have Hepatitis C Infection - Liver Health Information - The ...
If You Have Hepatitis C Infection. By ALF in collaboration with the Veterans Affairs Centers of Excellence in Research and Education for Hepatitis C ...

Hepatitis C Virus Infection in Cocaine Users: A Silent Epidemic
The presence of Hepatitis C infection in cocaine users who thought they were healthy suggests a silent epidemic in an unsuspecting population.

Living Well with Hepatitis C Virus Infection - BC HealthFile #40b
Symptoms of acute hepatitis C infection may include: fever, tiredness, jaundice [yellow skin or eyes], abdominal pain, dark urine, loss of appetite, ...

Hepatitis C: Plan: Infection | CDC Viral Hepatitis
Hepatitis C Infection in the United States. Hepatitis C virus (HCV) infection is the most common chronic bloodborne viral infection in the United States. ...

Hepatitis C in Pregnancy
Hepatitis C infection in patients with primary hypogammaglobulinemia after treatment with contaminated immune globulin. N Engl J Med. ...

Hepatitis G
Seven of the 16 patients with HGV/HGBV-C infection had concurrent hepatitis C infection and one was infected with hepatitis B. Of the 519 hemodialysis ...

Hepatitis C Therapy - Phoenix - Hepatitis C Continuing Medical Education (CME)


Phoenix - Hepatitis C Continuing Medical Education (CME)
Phoenix - Hepatitis C Continuing Medical Education (CME) Maria H. Sjogren, MD, MPH, FACP (Chairperson) Walter Reed Army Medical Center

Hepatitis C Resources and Information
Seeks to increase awareness of the worldwide problem of viral disease and to provide links to useful, informative sites.

Hepatitis C Information - Hepatitis C Symptoms - Hepatitis C
Find Hepatitis C Information, Hepatitis C Symptoms, Hepatitis C Treatments, Hepatitis-C Support Groups, Hepetitis-C and Hepatitis-C Virus Cures and News

Wisconsin Hepatitis C Program
Wisconsin Hepatitis C Program The Wisconsin Hepatitis C Program is the lead agency in Wisconsin responsible for coordinating the state's public health activities related to the prevention, detection

Public Health Agency of Canada - Hepatitis C - Home
Public Health Agency of Canada's home to all of our hepatitis C information.

Wednesday, March 22, 2006


Hepatitis C Therapy - GASTROINTESTINAL CARE - DOCTORS DRAW UP STRATEGY TO SAVE


GASTROINTESTINAL CARE - DOCTORS DRAW UP STRATEGY TO SAVE
ITNews, Italy - Mar 14, 2006... Alcoholic liver disease and obesity-related fatty liver disease are increasing at an "alarming rate" along with hepatitis C infection. ...

Hepatitis C Could Infect 800,000 Australians By 2020
MedIndia, India - Feb 22, 2006... be initiated. A 45 to 90% of patients can have their hepatitis C infection eradicated if interferon therapy is instituted. Liver ...

Transgene: 2005, A Year of Significant Achievements Paving the Way ...
CNW Telbec (Communiqu s de presse), Canada - Feb 22, 2006... Additionally, Transgene secured a EUR 1.3 million government grant for its TG 4040 (MVA-HCV) therapeutic vaccine programme against chronic hepatitis C infection ...

- Interim 12-Week Data Suggest At Least Comparable Antiviral ...
PR Newswire (press release), NY - Mar 14, 2006... week 12) Phase 2b virological efficacy and safety results of albumin interferon alfa-2b combined with ribavirin in genotype 1 chronic hepatitis C infection. ...

Tuesday, March 21, 2006


Hepatitis C Therapy - GoGirlsMusic.com Names HepCAware.org the Official Charity of the ...


GoGirlsMusic.com Names HepCAware.org the Official Charity of the ...
PR Web (press release), WA - Mar 4, 2006... a GoGirls member, has received a lot of support from Madalyn Sklar, founder of GoGirls, including a GoGirlsMusic Sponsorship for her annual "Hep C Aware -- The ...

Hep C symptom women need free care
Irish Medical Times, Ireland - Mar 8, 2006Dr Jerry Cowley, Mayo Independent TD, has called on the Government to provide free health care for a number of women suffering from Hepatitis C symptoms. ...

Hepatitis C - silent epidemic
Thunder Bay's Source, Canada - Feb 23, 2006... in attendance. The most common way to contract Hep C is through blood, and is often related to the sharing of needles. However thousands ...

Patients e-records facing legal hurdles
Kansas City Star, MO - Feb 28, 2006... The organization recently moved to 10603 Blue Ridge Blvd. There s no cure, and there s no vaccine for hep C, she said. ...

Ask the Doctor: Hepatitis C sufferers may get unwarranted stigma
Fort Wayne News Sentinel, IN - Mar 20, 2006... of transfer. Pain is a fact when dealing with hep C, regardless of age, gender, social status, or the decision to treat. And while ...

Hepatitis C Therapy - Feedster


Feedster
No Need to Click Here - I'm just claiming my feed at Feedster....

Liver Cancer, Hepatitis C Connection Gets Clearer
Title: Liver Cancer, Hepatitis C Connection Gets ClearerCategory: Health NewsCreated: 12/8/2005 1:59:00 AMLast Editorial Review: 12/8/2005 1:58:50 AM

Cirrhosis Of The Liver
Title: Cirrhosis Of The LiverCategory: Diseases and ConditionsCreated: 12/31/1997Last Editorial Review: 12/1/2005

Monday, March 20, 2006


Hepatitis C Therapy - Hepatitis C Virus Lives In Your Liver(NC)-Your liver

Hepatitis C Virus Lives In Your Liver

(NC)-Your liver works 24 hours a day, performing over 500 vital functions for your body. Most of the blood that returns to your heart passes through the liver. Your body can't function without it.

The hepatitis C virus lives in your liver. It inflames liver cells, which, over time, affects the way your liver functions. The effect of the hepatitis C virus varies from person to person. There is no way to predict how your body will react to it. There are, however, some things that are known:

You can live with hepatitis C for many years without experiencing any major symptoms, or you might simply feel tired. Symptoms can come and go over time. Their presence or absence does not tell you the degree to which liver damage may or may not be occurring. p>

Chronic, long-term inflammation of the liver can cause liver cell damage and result in fibrosis (liver scarring), or even cirrhosis. This damage can occur in as little as five years, or as long as 30 years.

About 20% of chronic hepatitis patients develop cirrhosis within 10 to 20 years.

Use of recreational drugs or alcohol can speed up inflammation and the development of fibrosis or cirrhosis.

There is an increased risk of liver cancer in people with cirrhosis.

The good news is that current drug treatments can be very effective for people with hepatitis C. Combined with proper nutrition, plenty of rest, and avoidance of recreational drugs and alcohol, these treatments help many who have the virus lead relatively healthy lives.

If you think you may be at risk of getting hepatitis C, see your doctor. The virus can be detected by a simple blood test. For more information on how to keep your liver happy and healthy, visit Health Canada's Web site at www.healthcanada.ca/hepc.

About The Author

p>

News Canada provides a wide selection of current, ready-to-use copyright free news stories and ideas for Television, Print, Radio, and the Web.

News Canada is a niche service in public relations, offering access to print, radio, television, and now the Internet media, with ready-to-use, editorial "fill" items. Monitoring and analysis are two more of our primary services. The service supplies access to the national media for marketers in the private, the public, and the not-for-profit sectors. Your corporate and product news, consumer tips and information are packaged in a variety of ready-to-use formats and are made available to every Canadian media organization including weekly and daily newspapers, cable and commercial television stations, radio stations, as well as the Web sites Canadians visit most often. Visit News Canada and learn more about the NC services. p>


Sunday, March 19, 2006


Hepatitis C Therapy - Intercell announces preliminary 2005 full year results: Good ...


Intercell announces preliminary 2005 full year results: Good ...
news aktuell (Pressemitteilung), Germany - Mar 5, 2006... these results, Intercell is now planning to test IC41 with this optimized schedule in a further Phase II trial in patients with chronic Hepatitis C. This study ...

Nature Reviews Drug Discovery Writes On AVI BioPharma's NEUGENE ...
Trading Markets, CA - Mar 7, 2006... AVI is currently enrolling patients with chronic hepatitis C infection in a Phase I/II clinical trial in the US The company has also reported early success in ...

Nabi Biopharmaceuticals to Present at the Lehman Brothers Ninth ...
PR Newswire (press release), NY - Mar 3, 2006... to prevent hepatitis C disease in HCV-positive liver transplant patients and is being evaluated for the treatment of chronic hepatitis C virus infections. ...

Clinical Trial Results Show That Peregrine's First-In-Class Anti ...
International News Service, Australia - Feb 27, 2006... that its first-in-class anti-viral compound Tarvacin(TM) Anti-Viral appeared safe and well-tolerated in a Phase l study in chronic hepatitis C virus (HCV ...

MIGENIX Third Quarter Fiscal 2006 Financial Results Conference ...
PR Newswire (press release), NY - Mar 2, 2006... The Company's clinical programs include drug candidates for the treatment of chronic Hepatitis C infections (Phase II), the prevention of catheter-related ...

Hepatitis C Therapy - Hemophilia, HIV, Hepatitis C HCV Lawsuit: 2006 Update


Hemophilia, HIV, Hepatitis C HCV Lawsuit: 2006 Update
Hemophiliacs around the world have filed lawsuits in the United States courts against American manufacturers for allegedly selling blood factor contaminated with HIV and/or Hepatitis C (HCV

Recommendations for Prevention and Control of Hepatitis C Virus (HCV
If HCV RNA is used to confirm anti-HCV results, a separate serum sample will need to be collected and handled in a manner suitable for RT-PCR. If the HCV RNA result is negative, supplemental anti

HCV Wireless
HCV Professional Services HCV Wireless Consulting, Systems Integration and Support Services The primary goal for HCV Wireless Professional Services is to support organisations to rapidly and effectively

HCV at CCWF
Hepatitis C (HCV) at the Central California Women's Facility (CCWF) Pamela Murphy, aka "PJ," was looking forward to her parole date in April, 2000. Looking forward to spending some quality time with

Profile Diagnostics, Inc., Research Panel HCV-VERSION RP-038
PROFILE DIAGNOSTICS, INC., Research Panel HCV-VERSION RP-038 The Profile Diagnostics, Inc. HCV-Version kit is an 8 member seroconversion panel for Hepatitis C

PharmaCare Pharmacy: Hepatitis-C - HCV, Hepatitis, Hep C Medication
This area of our site is comprised of HCV treatment, support, and Hepatitis C medication information and provides information on our pharmacy program and drug information specific to Hepatitis C